- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04586296
Tele-monitoring of Post Join Arthroplasty Outcomes: A Feasibility Study
Study Overview
Detailed Description
Upon patient education and consent to participate in this study, patients will be randomized via online randomizer during their baseline visit into either Treatment As Usual (TAU) or Integrated Voice Response (IVR) cohorts. During this baseline visit, the patients in the IVR group will be given specific information on the nature of the calls and what to expect. Both groups will fill out a form for assessing their baseline pain and functionality. Both groups will receive standard total joint arthroplasty. After this, the TAU group will receive the standard of care which involves appropriate pain management and scheduled clinic follow-ups lasting approximately 60 minutes at 2 weeks, 6 weeks, and 12 weeks along with additional visits if required. Clinic visits will assess pain via VAS scale, joint functionality via HOOS and KOOS scale, and quality of life via SF-36.
In addition to the standard of care follow-up visits as in the TAU group, the IVR group will also receive automated phone calls lasting up to 3 minutes, which will be the focus of this research study. These phone calls will be daily for the first week, every other day the second week, twice a week for weeks 3-6, and weekly for weeks 7-12. The content of these calls will assess pain management, wound healing and screen for potential complications through a series of questions (questionnaire script attached). At the completion of each call, the patient will be instructed to either continue standard treatment or visit the emergency department based on the content of their response. If there is reason for concern, the PI will automatically be informed.
Survey questions pertaining to the patients outcomes and satisfaction will be completed in clinic and collected by the PI. The responses and data relating to IVR calls will made available through computer software designed by our team on the secure REDcap network.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35205
- UAB Highland Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Participants eligible to undergo the TJA surgical procedure
Exclusion Criteria:
- Participants who are not eligible to undergo the TJA surgical procedure
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Telemedicine Group
Group that will be receiving the telemedicine intervention in addition to the standard of care post-op.
|
IVR will consist of a 3 minute call at a decreasing interval from the time of surgery.
Questions will assess pain control, signs of infection, prosthesis failure.
Other Names:
|
|
No Intervention: Standard Treatment
Patients will be receiving the standard of care, post op visits at 2, 6, and 12 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Percentage of Patients with acceptable pain control as measured by Visual Analogue scale
Time Frame: 2 week
|
VAS is a patient measured scale to evaluate pain, on a scale of 1-10 with 10 being the worst pain.
|
2 week
|
|
Percentage of Patients with acceptable pain control as measured by Visual Analogue scale
Time Frame: 6 weeks
|
VAS is a patient measured scale to evaluate pain, on a scale of 1-10 with 10 being the worst pain.
|
6 weeks
|
|
Percentage of Patients with acceptable pain control as measured by Visual Analogue scale
Time Frame: 12 weeks
|
VAS is a patient measured scale to evaluate pain, on a scale of 1-10 with 10 being the worst pain.
|
12 weeks
|
|
Percentage of Patients with acceptable pain control as measured by Visual Analogue scale
Time Frame: Baseline
|
VAS is a patient measured scale to evaluate pain, on a scale of 1-10 with 10 being the worst pain.
|
Baseline
|
|
Percentage of Patients with acceptable joint functionality as measured by hip disability and osteoarthritis outcome score (HOOS)
Time Frame: Baseline
|
HOOS is patient measured scores evaluating Hip function and creates a score out of 100, 100 indicating full functionality.
|
Baseline
|
|
Percentage of Patients with acceptable joint functionality as measured by hip disability and osteoarthritis outcome score (HOOS) and knee disability and osteoarthritis outcome score (KOOS)
Time Frame: Baseline
|
KOOS is a patient measured score evaluating Hip function and creates a score out of 100, 100 indicating full functionality.
|
Baseline
|
|
Percentage of Patients with acceptable joint functionality as measured by knee disability and osteoarthritis outcome score (KOOS)
Time Frame: 2 weeks
|
KOOS is a patient measured score evaluating knee function and creates a score out of 100, 100 indicating full functionality.
|
2 weeks
|
|
Percentage of Patients with acceptable joint functionality as measured by hip disability and osteoarthritis outcome score (HOOS)
Time Frame: 2 weeks
|
HOOS is a patient measured score evaluating knee function and creates a score out of 100, 100 indicating full functionality.
|
2 weeks
|
|
Percentage of Patients with acceptable joint functionality as measured by hip disability and osteoarthritis outcome score (HOOS)
Time Frame: 6 weeks
|
HOOS is a patient measured score evaluating Hip function and creates a score out of 100, 100 indicating full functionality.
|
6 weeks
|
|
Percentage of Patients with acceptable joint functionality as measured by knee disability and osteoarthritis outcome score (KOOS)
Time Frame: 6 weeks
|
KOOS is a patient measured score evaluating knee function and creates a score out of 100, 100 indicating full functionality.
|
6 weeks
|
|
Percentage of Patients with acceptable joint functionality as measured by hip disability and osteoarthritis outcome score (HOOS)
Time Frame: 12 weeks
|
HOOS is a patient measured scores evaluating Hip function and creates a score out of 100, 100 indicating full functionality.
|
12 weeks
|
|
Percentage of Patients with acceptable joint functionality as measured by knee disability and osteoarthritis outcome score (KOOS)
Time Frame: 12 weeks
|
KOOS is a patient measured score evaluating Hip and knee function and creates a score out of 100, 100 indicating full functionality.
|
12 weeks
|
|
Percentage of Patients with acceptable quality of life as measured by Short Form Health Survey SF-36
Time Frame: Baseline
|
The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section.
Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight.
The lower the score the more disability.
|
Baseline
|
|
Percentage of Patients with acceptable quality of life as measured by Short Form Health Survey SF-36
Time Frame: 2 weeks
|
The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section.
Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight.
The lower the score the more disability.
|
2 weeks
|
|
Percentage of Patients with acceptable quality of life as measured by Short Form Health Survey SF-36
Time Frame: 6 weeks
|
The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section.
Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight.
The lower the score the more disability.
|
6 weeks
|
|
Percentage of Patients with acceptable quality of life as measured by Short Form Health Survey SF-36
Time Frame: 12 weeks
|
The SF-36 consists of eight scaled scores, which are the weighted sums of the questions in their section.
Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight.
The lower the score the more disability.
|
12 weeks
|
Collaborators and Investigators
Investigators
- Principal Investigator: Sameer Naranje, MD, Assistant Professor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB-300005894
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post-Op Complication
-
Rigshospitalet, DenmarkCompletedComplication,Postoperative | Post-Op ComplicationDenmark
-
Cairo UniversityNot yet recruiting
-
Riphah International UniversityCompletedPost-Op ComplicationPakistan
-
Alexa CraigMaineHealthCompletedPost-Op ComplicationUnited States
-
Future University in EgyptRecruitingPost-Op ComplicationEgypt
-
Centre Hospitalier Régional Metz-ThionvilleCompletedPost-Op ComplicationFrance
-
NYU Langone HealthCompleted
-
Rothman Institute OrthopaedicsUnknown
-
Assiut UniversityCompleted
-
Cairo UniversityCompletedPost-Op Complication | Post Colo- Rectal Surgeries | Colo -Rectal SurgeriesEgypt
Clinical Trials on Telemedicine
-
NHS Greater Glasgow and ClydeUniversity of Strathclyde; Microsoft CorporationNot yet recruiting
-
University of RochesterAgency for Healthcare Research and Quality (AHRQ)CompletedTelemedicine | Physical DisordersUnited States
-
NHS Greater Glasgow and ClydeJean Brown Bequest Fund, Glasgow, UKNot yet recruitingTelemedicine | Surgery, PlasticUnited Kingdom
-
NHS Greater Glasgow and ClydeUniversity of Strathclyde; Microsoft CorporationCompletedTelemedicine | Reconstructive Surgery | 3 DimensionalUnited Kingdom
-
NHS Greater Glasgow and ClydeUniversity of Strathclyde; Glasgow Royal InfirmaryNot yet recruiting
-
University of California, San FranciscoCompleted
-
SciensanoEuropean CommissionRecruitingCancerHungary, Greece, Belgium, Cyprus, Ireland, Italy, Lithuania, Portugal, Slovenia, Spain
-
University of Cape TownKarolinska Institutet; University of California, San Francisco; Grand Challenges...Recruiting
-
Consorci Sanitari de l'Alt Penedès i GarrafCompleted
-
University Hospital MuensterPalliativnetz Muenster gGmbH; CompuGroup MedicalCompletedCancer | Chronic Obstructive Pulmonary Disease | Chronic Heart Failure | Palliative CareGermany